Cargando…
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
Breast cancer has the highest incidence and mortality in women worldwide. There are 70% of breast cancers considered as estrogen receptor α (ERα) positive. Therefore, the ERα-targeted therapy has become one of the most effective solution for patients with breast cancer. Whereas a better understandin...
Autores principales: | Xia, Xiaohong, Huang, Chuyi, Liao, Yuning, Liu, Yuan, He, Jinchan, Shao, Zhenlong, Hu, Tumei, Yu, Cuifu, Jiang, Lili, Liu, Jinbao, Huang, Hongbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997968/ https://www.ncbi.nlm.nih.gov/pubmed/33771975 http://dx.doi.org/10.1038/s41419-021-03607-w |
Ejemplares similares
-
USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36
por: Xia, Xiaohong, et al.
Publicado: (2020) -
Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment
por: Xia, Xiaohong, et al.
Publicado: (2020) -
Deubiquitination of CD36 by UCHL1 promotes foam cell formation
por: Xia, Xiaohong, et al.
Publicado: (2020) -
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
por: Xia, Xiaohong, et al.
Publicado: (2019) -
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
por: Liao, Yuning, et al.
Publicado: (2020)